Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|August 31, 2025
Efficacy of cyclin-dependent kinase 4/6 inhibitors in preclinical adult-type ovarian granulosa cell tumor modelsAllison L Brodsky, Thomas Welte, Veena K Vuttaradhi, et al.
International Journal of Molecular Sciences|February 25, 2023
Combination of EphA2- and Wee1-Targeted Therapies in Endometrial CancerSantosh K Dasari, Robiya Joseph, Sujanitha Umamaheswaran, et al.
NPJ Breast Cancer|May 27, 2024
Targeting neddylation and sumoylation in chemoresistant triple negative breast cancerReid T Powell, Amanda L Rinkenbaugh, Lei Guo, et al.
Frontiers in Pharmacology|December 23, 2022
Screening of GPCR drugs for repurposing in breast cancerNoor Mazin Abdulkareem, Raksha Bhat, Reid T Powell, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancerRongjie Fu, Yalong Wang, Ishita Rehman, et al.
The Journal of Clinical Endocrinology and Metabolism|June 13, 2021
A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid CarcinomaYing C Henderson, Abdallah S R Mohamed, Anastasios Maniakas, et al.
Molecular Cancer Therapeutics|September 29, 2021
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse ModelsKatelyn F Handley, Cristian Rodriguez-Aguayo, Shaolin Ma, et al.
Cancer Research Communications|May 21, 2026
Drug screening of sarcoma cells: finding shared sensitivitiesHannah C Beird, Carl Ho, Roberto Cardenas-Zuniga, et al.
Nucleic Acids Research|August 30, 2022
Chemically targeting the redox switch in AP1 transcription factor ΔFOSBAshwani Kumar, Galina Aglyamova, Yun Young Yim, et al.
International Journal of Molecular Sciences|January 27, 2024
EphA2- and HDAC-Targeted Combination Therapy in Endometrial CancerRobiya Joseph, Santosh K Dasari, Sujanitha Umamaheswaran, et al.
Pageof 5